{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:25:51Z","timestamp":1790889951021,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":3582,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1016\/j.jacc.2003.08.008","type":"journal-article","created":{"date-parts":[[2003,11,6]],"date-time":"2003-11-06T14:24:37Z","timestamp":1068128677000},"page":"1674-1676","source":"Crossref","is-referenced-by-count":9,"title":["Aldosterone antagonism and myocardial infarction"],"prefix":"10.1016","volume":"42","author":[{"given":"Scott D.","family":"Solomon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Pfeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2003.08.008_BIB1","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/01.CIR.54.6.849","article-title":"George C. Griffith lecture. The role of renin in normal and pathological cardiovascular homeostasis","volume":"54","author":"Haber","year":"1976","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2003.08.008_BIB2","doi-asserted-by":"crossref","first-page":"III36","DOI":"10.1161\/01.HYP.5.5_Pt_2.III36","article-title":"Renin system activity as a determinant of response to treatment in hypertension and heart failure","volume":"5","author":"Cody","year":"1983","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2003.08.008_BIB3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.0954-6820.1986.tb18122.x","article-title":"Effects of ACE-inhibition on regional circulation in congestive heart failure","volume":"707","author":"Swedberg","year":"1986","journal-title":"Acta Med Scand Suppl"},{"key":"10.1016\/j.jacc.2003.08.008_BIB4","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1073\/pnas.79.10.3310","article-title":"Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat","volume":"79","author":"Pfeffer","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl A","key":"10.1016\/j.jacc.2003.08.008_BIB5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/eurheartj\/4.suppl_A.143","article-title":"Prevention of the development of heart failure and the regression of cardiac hypertrophy by captopril in the spontaneously hypertensive rat","volume":"4","author":"Pfeffer","year":"1983","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2003.08.008_BIB6","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2003.08.008_BIB7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2003.08.008_BIB8","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement trial","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2003.08.008_BIB9","first-page":"821","article-title":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2003.08.008_BIB10","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(95)90865-X","article-title":"ISIS-4","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2003.08.008_BIB11","first-page":"1115","article-title":"GISSI-3. Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2003.08.008_BIB12","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1161\/hc4901.102568","article-title":"ACC\/AHA guidelines for the evaluation and management of chronic heart failure in the adult","volume":"104","author":"Hunt","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2003.08.008_BIB13","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0735-1097(99)00351-4","article-title":"1999 update","volume":"34","author":"Ryan","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2003.08.008_BIB14","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(97)01187-2","article-title":"Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan In The Elderly study, ELITE)","volume":"349","author":"Pitt","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2003.08.008_BIB15","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(00)02213-3","article-title":"Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure","volume":"355","author":"Pitt","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2003.08.008_BIB16","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2003.08.008_BIB17","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1161\/01.CIR.99.20.2658","article-title":"Augmented short- and long-term hemodynamic and hormonal effects of an angiotensin receptor blocker added to angiotensin-converting enzyme inhibitor therapy in patients with heart failure. Vasodilator Heart Failure Trial (V-HeFT) Study Group","volume":"99","author":"Baruch","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2003.08.008_BIB18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00877755","article-title":"\u201cEscape\u201d of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin-converting enzyme inhibitor","volume":"9","author":"Pitt","year":"1995","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacc.2003.08.008_BIB19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0002-9149(01)02261-5","article-title":"Relation of aldosterone \u201cescape\u201d despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy","volume":"89","author":"Cicoira","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2003.08.008_BIB20","doi-asserted-by":"crossref","unstructured":"Pfeffer MA, Swedberg R, Granger CB, et al., CHARM Investigators and Committees. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall Programme. Lancet 2003;362:759\u201366.","DOI":"10.1016\/S0140-6736(03)14282-1"},{"key":"10.1016\/j.jacc.2003.08.008_BIB21","first-page":"494","article-title":"Effect of spironolactone on experimental renovascular hypertension","volume":"16","author":"Atwill","year":"1965","journal-title":"Surg Forum"},{"key":"10.1016\/j.jacc.2003.08.008_BIB22","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2003.08.008_BIB23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00041552-199301000-00004","article-title":"The role of mechanical and humoral factors in growth regulation of vascular smooth muscle and cardiac myocytes","volume":"2","author":"Dzau","year":"1993","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2003.08.008_BIB24","first-page":"107","article-title":"Myocardial fibrosis","volume":"88","author":"Weber","year":"1993","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jacc.2003.08.008_BIB25","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0735-1097(00)00796-8","article-title":"Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure","volume":"36","author":"Tsutamoto","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2003.08.008_BIB26","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/01.HYP.33.4.981","article-title":"Angiotensin AT1 receptor subtype as a cardiac target of aldosterone. Role in aldosterone-salt-induced fibrosis","volume":"33","author":"Robert","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2003.08.008_BIB27","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1006\/jmcc.2002.2088","article-title":"Molecular mechanisms of myocardial remodeling. The role of aldosterone","volume":"34","author":"Delcayre","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jacc.2003.08.008_BIB28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3317\/jraas.2000.058","article-title":"Recruitable ACE and tissue repair in the infarcted heart","volume":"1","author":"Weber","year":"2000","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.jacc.2003.08.008_BIB29","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","article-title":"Aldosterone-induced inflammation in the rat heart","volume":"161","author":"Sun","year":"2002","journal-title":"Am J Pathol"},{"issue":"Suppl","key":"10.1016\/j.jacc.2003.08.008_BIB30","first-page":"57","article-title":"Renin-angiotensin system and myocardial fibrosis in hypertension","volume":"14","author":"Brilla","year":"1993","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2003.08.008_BIB31","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1161\/01.CIR.96.11.4065","article-title":"Extracellular matrix remodeling in heart failure. A role for de novo angiotensin II generation","volume":"96","author":"Weber","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2003.08.008_BIB32","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.jacc.2003.05.003","article-title":"Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction","volume":"42","author":"Fraccarollo","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2003.08.008_BIB33","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1527-3466.2001.tb00064.x","article-title":"Eplerenone","volume":"19","author":"Delyani","year":"2001","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.jacc.2003.08.008_BIB34","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s11906-000-0041-z","article-title":"The promise of selective aldosterone receptor antagonists for the treatment of hypertension and congestive heart failure","volume":"2","author":"Hameedi","year":"2000","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jacc.2003.08.008_BIB35","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109703010817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109703010817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T08:22:38Z","timestamp":1704961358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109703010817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["S0735109703010817"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2003.08.008","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}